Clinical relevant oncogenic drivers in advanced adenocarcinoma discloses new therapeutic target in negative EGFR/ALK/KRAS patients (2017)
- Authors:
- USP affiliated authors: CAPELOZZI, VERA LUIZA - FM ; NAGAI, MARIA APARECIDA - FM ; FABRO, ALEXANDRE TODOROVIC - FMRP
- Unidades: FM; FMRP
- Subjects: NEOPLASIAS PULMONARES; ADENOCARCINOMA; PULMÃO
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Journal of thoracic oncology
- ISSN: 1556-0864
- Volume/Número/Paginação/Ano: v. 12, n. 1, suppl.S, p. S955, res. P2.03b-034
- Conference titles: World conference on lun cancer - ASLC
-
ABNT
MACHADO, Juliana et al. Clinical relevant oncogenic drivers in advanced adenocarcinoma discloses new therapeutic target in negative EGFR/ALK/KRAS patients. Journal of thoracic oncology. New York: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://www.sciencedirect.com/journal/journal-of-thoracic-oncology/vol/12/issue/1/suppl/S. Acesso em: 28 abr. 2024. , 2017 -
APA
Machado, J., Nagai, M. A., Fabro, A. T., & Capelozzi, V. L. (2017). Clinical relevant oncogenic drivers in advanced adenocarcinoma discloses new therapeutic target in negative EGFR/ALK/KRAS patients. Journal of thoracic oncology. New York: Faculdade de Medicina, Universidade de São Paulo. Recuperado de https://www.sciencedirect.com/journal/journal-of-thoracic-oncology/vol/12/issue/1/suppl/S -
NLM
Machado J, Nagai MA, Fabro AT, Capelozzi VL. Clinical relevant oncogenic drivers in advanced adenocarcinoma discloses new therapeutic target in negative EGFR/ALK/KRAS patients [Internet]. Journal of thoracic oncology. 2017 ; 12( 1): S955.[citado 2024 abr. 28 ] Available from: https://www.sciencedirect.com/journal/journal-of-thoracic-oncology/vol/12/issue/1/suppl/S -
Vancouver
Machado J, Nagai MA, Fabro AT, Capelozzi VL. Clinical relevant oncogenic drivers in advanced adenocarcinoma discloses new therapeutic target in negative EGFR/ALK/KRAS patients [Internet]. Journal of thoracic oncology. 2017 ; 12( 1): S955.[citado 2024 abr. 28 ] Available from: https://www.sciencedirect.com/journal/journal-of-thoracic-oncology/vol/12/issue/1/suppl/S - Usefulness of complementary next-generation sequencing and quantitative immunohistochemistry panels for predicting brain metastases and selecting treatment outcomes of non-small cell lung cancer
- Mutation profile and protein expression for predictive testing in lung adenocarcinoma: a study of 200 patients from Brazil
- Next-generation sequencing of non-small cell lung cancer using a customized, targeted sequencing panel: focus on epithelial-mesenchymal transition
- Interobserver agreement of usual interstitial pneumonia diagnosis correlated with patient outcome
- Human pulmonary dirofilariasis mimicking malignancy: a case presentation
- Plasma-based circulating microRNA biomarkers as liquid biopsy for chronic thromboembolism pulmonary hypertension
- Mesenchymal stem cells and conditioned medium reduce fibrosis in pulmonary parenchyma but promote increased artery adventitia remodeling in bleomycin injured mice
- Adipose-derived mesenchymal stem cells and their conditioned medium modulate parenchyma remodeling through collagen V and Il-17 pathway in experimental pulmonary fibrosis
- Detection of sputum cofilin-1 as indicator of malignancy
- Intranasal administration of type V collagen reduces lung carcinogenesis through increasing endothelial apoptosis in a urethane-induced lung tumor model
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
